These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15132065)

  • 1. The role of insulin pumps in the management of diabetes.
    Everett J
    Nurs Times; 2004 Apr 20-26; 100(16):48-9. PubMed ID: 15132065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ketoacidosis in long-term therapy with insulin pumps. Incidence, causes, circumstances].
    Walter H; Günther A; Timmler R; Mehnert H
    Med Klin (Munich); 1989 Dec; 84(12):565-8. PubMed ID: 2516236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fulfilling the promise of insulin pump therapy in childhood diabetes.
    Tamborlane WV
    Pediatr Diabetes; 2006 Aug; 7 Suppl 4():4-10. PubMed ID: 16774611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Guidelines concerning insulin dosage in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion].
    Szypowska A; Pańkowska E; Lipka M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):45-50. PubMed ID: 16704861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes.
    Eugster EA; Francis G;
    Pediatrics; 2006 Oct; 118(4):e1244-9. PubMed ID: 17015512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ketoacidosis during insulin pump therapy--an acceptable risk?].
    Walter H; Mehnert H
    Dtsch Med Wochenschr; 1989 May; 114(18):722-5. PubMed ID: 2496966
    [No Abstract]   [Full Text] [Related]  

  • 7. Current status and future of implantable insulin pumps for the treatment of diabetes.
    Catargi B
    Expert Rev Med Devices; 2004 Nov; 1(2):181-5. PubMed ID: 16293038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Insulin pumps for insulin-dependent diabetics].
    Millet P; Selam JL; Boudet C
    Annee Ther Clin Ophtalmol; 1983; 34():99-109. PubMed ID: 6679709
    [No Abstract]   [Full Text] [Related]  

  • 9. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].
    Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Restoring treatment with continuous insulin infusion pump (BICI)].
    Méndez López AM
    Rev Enferm; 2008 Jun; 31(6):43-8. PubMed ID: 18724516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Continuous subcutaneous insulin infusion (CSII) in treating young diabetic patients].
    Buczkowska EO; Dworzecki T; Wiedermann G; Malanowicz B; Szot D
    Przegl Lek; 2005; 62(1):49-53. PubMed ID: 16053222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of insulin pumps for diabetes management.
    Webb KE
    Medsurg Nurs; 2006 Apr; 15(2):61-8, 94; quiz 69. PubMed ID: 16700243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Diabetes Control and Complications Trial (DCCT). A milestone in diabetes management.
    Chrisholm DJ
    Med J Aust; 1993 Dec 6-20; 159(11-12):721-3. PubMed ID: 8264454
    [No Abstract]   [Full Text] [Related]  

  • 14. Feasibility and safety of insulin pump therapy in children aged 2 to 7 years with type 1 diabetes: a retrospective study.
    Berhe T; Postellon D; Wilson B; Stone R
    Pediatrics; 2006 Jun; 117(6):2132-7. PubMed ID: 16740857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic control with insulin pump therapy: the Waikato experience.
    Reda E; Von Reitzenstein A; Dunn P
    N Z Med J; 2007 Jan; 120(1248):U2401. PubMed ID: 17277817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Personal insulin pumps--from experiment research till recommended method of diabetes treatment].
    Mozdzan M; Ruxer J; Loba J
    Pol Merkur Lekarski; 2005 Oct; 19(112):577-9. PubMed ID: 16379330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment with insulin pump during hospital care should be questioned. Three cases illustrate the risk of ketoacidosis].
    Gubrianska D; Moberg E; Palmér M
    Lakartidningen; 2009 Aug 5-18; 106(32-33):1967-8. PubMed ID: 19764373
    [No Abstract]   [Full Text] [Related]  

  • 18. Diabetic ketoacidosis in pregnancy resulting from insulin pump failure. A case report.
    Lindenbaum C; Menzin A; Ludmir J
    J Reprod Med; 1993 Apr; 38(4):306-8. PubMed ID: 8501740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of insulin glulisine when given by continuous subcutaneous infusion using an external pump in patients with type 1 diabetes.
    Hoogma RP; Schumicki D
    Horm Metab Res; 2006 Jun; 38(6):429-33. PubMed ID: 16823727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why pumps? Continuous subcutaneous insulin infusion for children and adolescents with type 1 diabetes.
    Weintrob N; Shalitin S; Phillip M
    Isr Med Assoc J; 2004 May; 6(5):271-5. PubMed ID: 15151365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.